Sign in
WithdrawnNo phase

Diagnosis and Treatment of Periodontal Disease in Patients With AML

Key facts

Who runs it
Masonic Cancer Center, University of Minnesota
Trial code
Status
Withdrawn
Started
May 2022
Expected to end
Nov 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Scaling and Root Planing
Record updated
22 February 2023
Why it stopped
PI left institution and research was cancelled due to his departure

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age >18 years
  • Newly diagnosed or relapsed AML
  • Planned intensive chemotherapy (Any regimen expected to require 3-4 weeks of inpatient stay)
  • Antibacterial prophylaxis using levofloxacin 500 mg daily
  • Sufficient time to perform periodontal examination and treatment by day 1 of chemotherapy

Who cannot take part

  • Prior treatment for AML, except hydroxyurea or leukapheresis
  • Documented infection at the time of enrollment
  • Symptomatic periodontal disease
  • ANC <0.5 x 10\^9/L at the time of enrollment
  • Post-transfusion platelet count <50x10\^9/L at the time of enrollment
  • Unstable for transfer to the School of Dentistry
  • Fever at the time of enrollment
  • SRP in the last 3 months

About the trial

What the trial wants to find out

This is a phase 2 randomized controlled trial of pre-chemotherapy periodontal deep cleaning in Acute Myelogenous Leukemia (AML) patients with asymptomatic periodontitis.

Read full original descriptionShow less

Once eligibility is confirmed, participants with periodontitis will be randomized in a 1:1 ratio to undergo treatment by scaling and root planing (SRP, "deep cleaning") (arm A) or receive no periodontal treatment (arm B). We will compare the incidence of Blood Stream Infection (BSI) during chemotherapy between the two arms.

Study participation will continue until day 28 of chemotherapy or discharge from hospital, whichever occurs first.

The 2 groups in the trial

  • Arm A: Deep CleaningTreatment being tested

    participants with periodontitis will undergo treatment by scaling and root planing (SRP)

    Treatment: Scaling and Root Planing

  • Arm B: No cleaningNo study treatment, for comparison

    participants with periodontitis will undergo no periodontal treatment

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Diagnosis and Treatment of Periodontal Disease in Patients With AML to Reduce Bloodstream Infections During Chemotherapy
Record updated
22 February 2023